SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-20-020291
Filing Date
2020-02-13
Accepted
2020-02-13 17:06:01
Documents
2
Group Members
DALIA BLEYERJAMES PLEDGERNEXTECH V GP S.A R.L.THOMAS LIPS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm207791d1_sc13ga.htm SC 13G/A 109893
2 EXHIBIT 99.1 tm207791d1_ex99-1.htm EX-99.1 6590
  Complete submission text file 0001104659-20-020291.txt   118307
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Subject) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90647 | Film No.: 20611854
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748
Business Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748 352-246-160-6000
Nextech V Oncology S.C.S., SICAV-SIF (Filed by) CIK: 0001712922 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G/A